Louise Johanna Maria Alferink

7PUBLICATIONS
15CO-AUTHORS
ChemotherapyMechanobiologyGene expression (incl. microarray and other genome-wide approaches)Nutrigenomics and personalised nutritionFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 05, 2024
Editorial: Navigating the Beta-Blocker Dilemma in Advanced Liver Cirrhosis-When Is the Right Time to Discontinue?

Louise J M Alferink, Robert J de Knegt

|Aug 28, 2021
Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.

Laurens A van Kleef, Ibrahim Ayada, Louise J M Alferink

|Jun 13, 2020
Microbiomics, Metabolomics, Predicted Metagenomics, and Hepatic Steatosis in a Population-Based Study of 1,355 Adults.

Louise J M Alferink, Djawad Radjabzadeh, Nicole S Erler

|May 11, 2019
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.

Louise Johanna Maria Alferink, Katerina Trajanoska, Nicole Stephanie Erler

|Nov 23, 2018
Animal protein intake and hepatic steatosis in the elderly: authors' response.

Louise Johanna Maria Alferink, Jessica Christina Kiefte-de Jong, Sarwa Darwish Murad

|Aug 02, 2018
Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study.

Louise Jm Alferink, Jessica C Kiefte-de Jong, Nicole S Erler

Pageof 2

Frequent Collaborators

3 joint publications

Robert J de Knegt

2 joint publications

Jessica Christina Kiefte-de Jong

1 joint publications

Rosalie C Oey

1 joint publications

Bettina E Hansen